Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breathomics as a Non-invasive, Inexpensive, Point-of-care Predictive Test for Immune Checkpoint Inhibitor Efficacy

NCT04146064 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT04146064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04146064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breathomics as a Non-invasive, Inexpensive, Point-of-care Predictive Test for Immune Checkpoint Inhibitor Efficacy
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Completed
Start date
February 24, 2020
Completion date
February 9, 2026
Enrollment
190 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, kidney cancer, melanoma, nsclc, urothelial carcinoma